Evaluation of the effect of nicotinic acid (niacin) on elevated lipoprotein(a) levels (NICOLa Study).

Trial Profile

Evaluation of the effect of nicotinic acid (niacin) on elevated lipoprotein(a) levels (NICOLa Study).

Discontinued
Phase of Trial: Phase III

Latest Information Update: 05 Aug 2015

At a glance

  • Drugs Niacin (Primary)
  • Indications Hyperlipoproteinaemias
  • Focus Therapeutic Use
  • Acronyms NICOLa
  • Most Recent Events

    • 05 Aug 2009 Planned end date changed from 1 Jan 2009 to 1 Mar 2010 as reported by ClinicalTrials.gov.
    • 05 Aug 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 01 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top